Advertisement

Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 600x60px
Document › Details

Macrolide Pharmaceuticals, Inc.. (4/2/18). "Press Release: Macrolide Pharmaceuticals Appoints New President and CEO. Raises $20 Million in Investor Financing".

Organisation Organisation SR One Ltd.
  Group GlaxoSmithKline (GSK) (Group)
Products Product antibiotic
  Product 2 venture capital
Person Person Skinner, Henry (Novartis 201201 Managing Director of Novartis Venture Funds)
     


Macrolide Pharmaceuticals, a next-generation antibiotics company developing macrolides that are first-in-class with Gram-negative activity for a broad range of multi-drug resistant bacterial infections, today announced that Mahesh Karande has joined the company as President and CEO. The company is also pleased to announce the completion of a $20 million financing led by current investors Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One.

“This latest financing represents the strong confidence from our investors in the path-breaking approach we are taking to address unmet needs in the antibiotic landscape. This positions Macrolide to further the pioneering work the team has done to date in advancing new macrolide antibiotics with Gram-negative activity,” said Mr. Karande. “We believe that advancing first-in-class antibiotics that are active against lethal multi-drug resistant bacteria opens the door to a new and meaningful way to address the growing public health issue of treatment gaps due to antibiotic resistance.”

Mr. Karande has held increasing responsibilities at Novartis AG where he ran large businesses in the US and internationally. He served as Vice President and U.S. Oncology Business Head for Breast and Renal Solid Tumors, President and Pharma Head for Africa and Egypt, and Head of Strategy and Business Development for Asia-Pacific, Middle East and Africa. He has deep and broad global experiences in operations, strategy, policy, licensing and partnering. He joins Macrolide from Intarcia Therapeutics where he served as Vice President and General Manager.

“We are excited to have Mahesh join the team at Macrolide Pharmaceuticals and bring his considerable experience in leadership, business-building, policy and strategy to the company at this important juncture,” said Henry Skinner, Chairman of the Board.

The new funding from both the financing and previously announced CARB-X award will accelerate development of the company’s novel, IV and orally-available macrolide antibiotics to address serious infections, including work to support filing an Investigational New Drug (IND) application for its lead program that addresses a significant unmet clinical need that exists for antibiotics to treat infections caused by resistant Gram-negative pathogens. The company is broadly pursuing novel macrolide antibiotics for several illnesses caused by Gram-negative pathogens for which a critical unmet clinical need exists.


Contacts

Macrolide Pharmaceuticals

Company Contact
Mahesh Karande
mkarande@macrolide.com

or

Macrolide Pharmaceuticals Media Contact
Ten Bridge Communications
Krystle Gibbs, 508-479-6358
krystle@tenbridgecommunications.com

   
Record changed: 2018-04-16

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px